Noncolorectal Gastrointestinal Cancer

Noncolorectal Gastrointestinal Cancer News

  • TAS-102 Could Tackle Unmet Need in Advanced Gastric Cancer Patients with advanced/metastatic gastric cancer could experience a significant increase in overall survival with combination TAS-102 compared with placebo, phase 3 trial results indicate.
  • Ramucirumab Improves Survival in Poor-Prognosis HCC Patients with hepatocellular carcinoma who have high levels of a protein linked to a poor prognosis derive a significant survival benefit with ramucirumab, the results of a pooled analysis reveal.
 

Noncolorectal Gastrointestinal Cancer Perspective

 

Journals